141
Views
0
CrossRef citations to date
0
Altmetric
Psychotherapeutics Column

Classic Monoamine Oxidase Inhibitors for Depression: Update on Nursing Care

, LL.MORCID Icon, , MA (Oxon.), , RN & , MD
Pages 138-139 | Published online: 05 Dec 2022
 

Authors’ contributions

VVdE and LG contributed equally.

Disclosure statement

VVdE is an external research consultant for, and receives or has received consulting fees from: PsychoTropical Research, NeuraWell Therapeutics, Aristo Pharma GmbH; he has stock options in NeuraWell Therapeutics. LG has nothing to report. ST has received fees from NeuraWell Therapeutics for research unrelated to the present manuscript. PKG has equity interests in, and is on the advisory board of NeuraWell Therapeutics, the company that has the patent for a modified form of tranylcypromine.

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 304.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.